Apixaban thromboprophylaxis in ambulatory patients with cancer and obesity: Insights from the AVERT trial.
暂无分享,去创建一个
M. Di Nisio | Nicola Potere | E. Porreca | V. Tagalakis | A. Delluc | R. Mallick | P. Wells | M. Carrier | Tzu‐Fei Wang | S. Shivakumar